211 related articles for article (PubMed ID: 14967416)
21. Does off-pump coronary artery bypass surgery reduce secretion of plasminogen activator inhibitor-1?
Ozkara C; Guler N; Batyraliev T; Okut H; Agirbasli M
Int J Clin Pract; 2007 May; 61(5):763-7. PubMed ID: 17343662
[TBL] [Abstract][Full Text] [Related]
22. Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
J Thromb Haemost; 2007 Feb; 5(2):313-20. PubMed ID: 17092303
[TBL] [Abstract][Full Text] [Related]
23. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
[TBL] [Abstract][Full Text] [Related]
24. Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver.
Seki T; Imai H; Uno S; Ariga T; Gelehrter TD
Thromb Haemost; 1996 May; 75(5):801-7. PubMed ID: 8725727
[TBL] [Abstract][Full Text] [Related]
25. The role of the finger domain of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in initiation and progression of thrombolysis.
Stringer HA; van Swieten P; Horrevoets AJ; Smilde A; Pannekoek H
Thromb Haemost; 1994 Dec; 72(6):900-5. PubMed ID: 7740461
[TBL] [Abstract][Full Text] [Related]
26. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
[TBL] [Abstract][Full Text] [Related]
27. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
28. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.
Javed Q; Swanson N; Warner EL; Gershlick AH; de Bono DP
Exp Mol Pathol; 2001 Apr; 70(2):146-53. PubMed ID: 11263957
[TBL] [Abstract][Full Text] [Related]
30. Genetic markers of fibrinolytic responses of older persons to exercise training.
Kulaputana O; Ghiu I; Phares DA; Ferrell RE; Macko RF; Goldberg AP; Hagberg JM
Int J Sports Med; 2006 Aug; 27(8):617-22. PubMed ID: 16874588
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor-1 and tissue-type plasminogen activator are up-regulated during unilateral ureteral obstruction in adult rats.
Ishidoya S; Ogata Y; Fukuzaki A; Kaneto H; Takeda A; Orikasa S
J Urol; 2002 Mar; 167(3):1503-7. PubMed ID: 11832778
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
Valen G; Eriksson E; Risberg B; Vaage J
Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
[TBL] [Abstract][Full Text] [Related]
33. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
34. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
[TBL] [Abstract][Full Text] [Related]
35. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients.
Fernandez-Cadenas I; Alvarez-Sabin J; Ribo M; Rubiera M; Mendioroz M; Molina CA; Rosell A; Montaner J
J Thromb Haemost; 2007 Sep; 5(9):1862-8. PubMed ID: 17723126
[TBL] [Abstract][Full Text] [Related]
36. Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats.
Wang L; Kittaka M; Sun N; Schreiber SS; Zlokovic BV
J Cereb Blood Flow Metab; 1997 Feb; 17(2):136-46. PubMed ID: 9040492
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
[TBL] [Abstract][Full Text] [Related]
38. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia].
Wu X; Wang CF; Sheng J; Zhu J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613
[TBL] [Abstract][Full Text] [Related]
39. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
Ray MJ; Marsh NA; Hawson GA
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
[TBL] [Abstract][Full Text] [Related]
40. [Tissue plasminogen activator antigen (t-PA Ag) and tissue plasminogen activator inhibitor (PAI-1) in the course of hemodialysis in patients with chronic renal failure].
Piatkowska M; Kotschy M; Nartowicz E; Rajewski W
Pol Merkur Lekarski; 1997 Jan; 2(9):205-7. PubMed ID: 10907030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
